Clinical Applications of Hallucinogens, Dissociatives and Other Schedule I Drugs
.custom-column-left-text {
float: left;
width: 50%;
padding-right: 10px;
}
.custom-column-right-text {
float: right;
width: 45%;
text-align:center;
}
@media only screen and (max-width: 600px) {
.custom-column-left-text,
.custom-column-right-text,
.custom-column-flc-ebook-text {
float:none;
width:80%;
margin:0 auto;
}
}
Following an initial period of study, mainly in the early 20th century, many hallucinogenic drugs had been dismissed as drugs of abuse with no clinical utility.
Saving You Time With Tell Us Once™
BioPharma Dive: Ligand Binding Program Considerations — The Value of Preclinical to Clinical Bioanalytical Expertise
Snuggle Wrap-based Restraint Method of Continuous Infusion in Juvenile Nonhuman Primates
Historical Control Database of Cynomolgus Macaque Spermatozoa
Determination of Normal: Flow Cytometry Analysis of Major Immune Cell Populations in Peripheral Blood of Naïve Cynomolgus Monkeys
Assessment of Subcutaneous Radio-Telepathy Device Implantation in Cynomolgus Monkeys
Assessment of Receptor Occupancy via Flow Cytometry: Benefits and Pitfalls of Two Common Approaches